Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.96 |
| ▸ | CNR2 | P34972 | 3/20 | 0.67 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.61 |
| ▸ | RELA | Q04206 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinaldic Acid SCHEMBL39024 | 0.98 | MGAM (1.00) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL29350584 | 0.98 | MGAM (1.00) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL1242670 | 0.98 | MGAM (1.00) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL13571793 | 0.96 | MGAM (0.96) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL5228672 | 0.96 | MGAM (0.96) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL2372429 | 0.96 | MGAM (0.96) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL4587213 | 0.96 | MGAM (0.96) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL4588314 | 0.96 | MGAM (0.96) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL4802724 | 0.96 | MGAM (0.96) | MGAMCNR2HDAC8SMN1; SMN2RAB9A | |
| Quinaldic Acid SCHEMBL8798794 | 0.96 | MGAM (0.96) | MGAMCNR2HDAC8SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116713121-A | Flotation reagent combination for improving recovery of associated gold, silver, platinum and palladium minerals in chalcopyrite | 商洛学院 | 2023-09-08 | — | — | CN | claimed |
| CN-116713121-A | Flotation reagent combination for improving recovery of associated gold, silver, platinum and palladium minerals in chalcopyrite | 商洛学院 | 2023-09-08 | — | — | CN | disclosed |
| CN-116713121-A | Flotation reagent combination for improving recovery of associated gold, silver, platinum and palladium minerals in chalcopyrite | 商洛学院 | 2023-09-08 | — | — | CN | disclosed |
| CN-104195533-B | A kind of nickel zinc phosphorus chemical plating and preparation method thereof and chemical plating fluid | 国家电网公司 | 2016-08-31 | — | — | CN | disclosed |
| CN-100482672-C | novel 14 and 15 membered ring compounds | GLAXO GROUP LTD (GB) | 2009-04-29 | — | — | CN | disclosed |
| EP-1824871-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2007-08-29 | — | — | EP | disclosed |
| EP-1628989-B1 | NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS | GLAXO GROUP LTD (GB) | 2006-12-20 | — | — | EP | disclosed |
| CN-1852912-A | Novel 14 and 15 membered-ring compounds | GLAXO GROUP LTD (GB) | 2006-10-25 | — | — | CN | disclosed |
| CN-1849328-A | Novel 14 and 15 membered-ring compounds | GLAXO GROUP LTD (GB) | 2006-10-18 | — | — | CN | disclosed |
| EP-1628988-B1 | NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS | GLAXO GROUP LTD (GB) | 2006-10-04 | — | — | EP | disclosed |
| CN-1820017-A | Macrolides substituted at the 4 \"position | GLAXO GROUP LTD (GB) | 2006-08-16 | — | — | CN | disclosed |
| WO-2006050940-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2006-05-18 | — | — | WO | disclosed |
| EP-1628989-A1 | NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2006-03-01 | — | — | EP | disclosed |
| EP-1628988-A1 | NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2006-03-01 | — | — | EP | disclosed |
| WO-2004101586-A1 | NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101587-A1 | NOVEL 14 AND 15 MEMBERRED-RING COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
| CN-1130346-C | Tetrahydroquinolines as NMDA antagonists | GLAXO WELLCOME SPA (IT) | 2003-12-10 | — | — | CN | disclosed |
| EP-0854867-A1 | TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS | GLAXO WELLCOME S.p.A. (IT) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997012870-A1 | TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS | GLAXO WELLCOME S.P.A. (IT) | 1997-04-10 | — | — | WO | disclosed |